Retrieved on May 2, 2025 from Borrelli, S., Provenzano, M., Gagliardi, I., et al
Insist on transparency about sourcing and lab testing for any injectable you receive
While Semaglutide GLP-1 is broadly applicable for many patients struggling with significant weight-related concerns, it is not suitable for everyone
Consistent weight loss of at least 1% of starting body weight per month, reduced hunger between doses, quieter food noise and more manageable portion sizes are the main indicators
GLP-1s to be made available to Hoosiers through Medicaid INDIANAPOLIS (WISH) Eligible Hoosiers will now be able to receive select GLP-1 medications through Medicaid, according to Governor Mike Braun